MedPath

To study the effectiveness of psychological therapy in patients with schizophrenia

Not Applicable
Conditions
Health Condition 1: F20- Schizophrenia
Registration Number
CTRI/2019/02/017658
Lead Sponsor
Dr B Ravishankar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.primary diagnosis of schizophrenia confirmed by Mini International Neuropsychiatric Interview (M.I.N.I), supplemented by DSM-V and clinical diagnosis.

2.participants should have at least 8 years of education

3.participants should have provided informed consent

4.participants should be able to read and speak Tamil language

5.all participant should be symptomatically stable at the time of enrollment,

6.Positive and Negative Syndrome Scale (PANSS) scores should be under 75, ratings of 3 (mild) or less on the PANSS psychosis items.

Exclusion Criteria

1.any co-morbid psychiatric disorder, neurological disorders

2.history of substance or alcohol, formal thought disorder, aggressive behavior

3.IQ <70

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome Name: <br/ ><br>â?¢Score on Positive and Negative Symptom Scale (PANSS) <br/ ><br>Expected Outcome: <br/ ><br>â?¢The experimentalintervention group is expected to show 40% reduction in the PANSS score whereas the control or the treatment as usual group is expected to show 10% reduction in the PANSS score. <br/ ><br>Timepoint: After 2 weeks, 6 months and 1 year of completion of intervention
Secondary Outcome Measures
NameTimeMethod
â?¢To study the effect of metacognitive therapy on patientâ??s insight <br/ ><br>â?¢To study the relationship of positive symptom(as assessed by PANSS)and insight <br/ ><br>â?¢To study the effect of metacognitive therapy on the patientâ??s beliefs <br/ ><br>â?¢To study if the metacognitive therapy improves patientâ??s metacognitive functioning <br/ ><br>â?¢To study if effect of metacognitive therapy on patientâ??s functioningTimepoint: 2 weeks, 6 months and one year after the intervention termination.
© Copyright 2025. All Rights Reserved by MedPath